To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...
See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New York Times on GoogleAgrega The New York Times en Google On Tuesday, I ...
Glenmark Pharmaceuticals on Friday said its US-based unit is gearing up to introduce a generic sodium phosphates injection in the American market. The Mumbai-based drug firm said its product is ...
Zydus and its wholly owned US subsidiary will pay Astellas a total of 120 million dollars under the terms of the agreement disclosed on February 12, 2026. The settlement ends all litigation between ...
The following is a news release from the Idaho Attorney General's Office: BOISE, Idaho — On February 2, 2026, Attorney General Labrador joined a coalition of 48 states and territories announcing ...
Three Republican-led states have challenged the Food and Drug Administration’s (FDA) approval of a generic form of the abortion pill mifepristone earlier this year, arguing the agency’s decision had ...
BlackLine has ambitions to automate the Office of the CFO with AI, but not of the "generic dangerous" variety, says CTO Jeremy Ung. AI on its own isn't the product. Thank you Owen Ryan, co-CEO at ERP ...
Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...
Patent thickets extend market exclusivity, delaying generic competition and increasing drug costs, with $3.5 billion in excess spending identified for four drugs over two years. The study found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results